English | Español
Patient Daily | Mar 22, 2026

Pfizer reports phase 2 trial results for Ibrance successor in breast cancer treatment
Patient Daily | Mar 22, 2026

AI drug discovery platforms face new challenges in attracting investors
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
Patient Daily | Mar 22, 2026

Study links gut microbe molecules to coronary heart disease risk

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

FDA’s new priority voucher program faces questions over transparency and selection process
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Researchers identify hormone-driven growth in lethal pediatric brain tumor
+ Regulatory
Patient Daily | Mar 30, 2026

Biotechnology Innovation Organization survey finds strong voter support for PBM reforms